{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:19:02Z","timestamp":1778581142104,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","thrombosisresearch.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.thromres.2017.06.038","type":"journal-article","created":{"date-parts":[[2017,7,2]],"date-time":"2017-07-02T02:00:15Z","timestamp":1498960815000},"page":"72-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Inhibitory effects of ASP6537, a selective cyclooxygenase-1 inhibitor, on thrombosis and neointima formation in rats"],"prefix":"10.1016","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0472-8002","authenticated-orcid":false,"given":"Chinatsu","family":"Sakata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6050-5893","authenticated-orcid":false,"given":"Tomihisa","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Iwatsuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Moritani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideaki","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2017.06.038_bb0005","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000366","article-title":"Heart disease and stroke statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2017.06.038_bb0010","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11886-016-0756-3","article-title":"Revascularization strategies in patients with diabetes mellitus and acute coronary syndrome","volume":"18","author":"Buntaine","year":"2016","journal-title":"Curr. Cardiol. Rep."},{"key":"10.1016\/j.thromres.2017.06.038_bb0015","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00392-016-1013-x","article-title":"Cardiac surgery 2015 reviewed","volume":"105","author":"Doenst","year":"2016","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.thromres.2017.06.038_bb0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11883-016-0581-6","article-title":"Antiplatelet management for coronary heart disease: advances and challenges","volume":"18","author":"Gillette","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.thromres.2017.06.038_bb0025","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/CIRCULATIONAHA.106.675934","article-title":"Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications","volume":"115","author":"Luscher","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2017.06.038_bb0030","doi-asserted-by":"crossref","first-page":"20130852","DOI":"10.1098\/rsif.2013.0852","article-title":"Biomechanical regulation of vascular smooth muscle cell functions: from in vitro to in vivo understanding","volume":"11","author":"Qiu","year":"2014","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.thromres.2017.06.038_bb0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11936-015-0365-2","article-title":"Stent thrombosis: current management and outcomes","volume":"17","author":"Sommer","year":"2015","journal-title":"Curr. Treat. Options Cardiovasc. Med."},{"key":"10.1016\/j.thromres.2017.06.038_bb0040","first-page":"93","article-title":"Prevention of stent thrombosis: challenges and solutions","volume":"11","author":"Reejhsinghani","year":"2015","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.thromres.2017.06.038_bb0045","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/S0140-6736(13)61720-1","article-title":"Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2year results from a prospective observational study","volume":"382","author":"Mehran","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2017.06.038_bb0050","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.bcp.2011.06.035","article-title":"Pharmacological profile of FK881(ASP6537), a novel potent and selective cyclooxygenase-1 inhibitor","volume":"82","author":"Imanishi","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.thromres.2017.06.038_bb0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.thromres.2013.03.005","article-title":"ASP6537, a novel highly selective cyclooxygenase-1 inhibitor, exerts potent antithrombotic effect without \u201caspirin dilemma\u201d","volume":"132","author":"Sakata","year":"2013","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2017.06.038_bb0060","doi-asserted-by":"crossref","first-page":"18947","DOI":"10.1074\/jbc.M116.739722","article-title":"Thromboxane A2 activates YAP\/TAZ protein to induce vascular smooth muscle cell proliferation and migration","volume":"291","author":"Feng","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.thromres.2017.06.038_bb0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1161\/01.HYP.28.2.169","article-title":"Thromboxane\/prostaglandin endoperoxide-induced hypertrophy of rat vascular smooth muscle cells is signaled by protein kinase C-dependent increases in transforming growth factor-beta","volume":"28","author":"Craven","year":"1996","journal-title":"Hypertension"},{"key":"10.1016\/j.thromres.2017.06.038_bb0070","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/01.CIR.97.6.589","article-title":"Thrombin-induced mitogenesis in coronary artery smooth muscle cells is potentiated by thromboxane A2 and involves upregulation of thromboxane receptor mRNA","volume":"97","author":"Zucker","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2017.06.038_bb0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1165\/ajrcmb.26.2.4695","article-title":"Differential effects of stable prostacyclin analogs on smooth muscle proliferation and cyclic AMP generation in human pulmonary artery","volume":"26","author":"Clapp","year":"2002","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.thromres.2017.06.038_bb0080","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/sj.bjp.0704749","article-title":"Effects of the prostanoids on the proliferation or hypertrophy of cultured murine aortic smooth muscle cells","volume":"136","author":"Fujino","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.thromres.2017.06.038_bb0085","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.atherosclerosis.2007.01.010","article-title":"Prostacyclin synthase gene transfer inhibits neointimal formation by suppressing PPAR delta expression","volume":"195","author":"Imai","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.thromres.2017.06.038_bb0090","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/01.CIR.92.5.1230","article-title":"Smooth muscle cell proliferation is proportional to the degree of balloon injury in a rat model of angioplasty","volume":"92","author":"Indolfi","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2017.06.038_bb0095","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4330\/wjc.v8.i6.362","article-title":"Thrombosis in ST-elevation myocardial infarction: insights from thrombi retrieved by aspiration thrombectomy","volume":"8","author":"Ribeiro","year":"2016","journal-title":"World J. Cardiol."},{"key":"10.1016\/j.thromres.2017.06.038_bb0100","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.jacc.2010.09.077","article-title":"Composition of coronary thrombus in acute myocardial infarction","volume":"57","author":"Silvain","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2017.06.038_bb0105","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.thromres.2009.11.010","article-title":"Composition of thrombi in late drug-eluting stent thrombosis versus de novo acute myocardial infarction","volume":"126","author":"Nishihira","year":"2010","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2017.06.038_bb0110","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1055\/s-0038-1648133","article-title":"The characterisation of thrombus development in an improved model of arterio-venous shunt thrombosis in the rat and the effects of recombinant desulphatohirudin (CGP 39393), heparin, and iloprost","volume":"65","author":"Peters","year":"1991","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2017.06.038_bb0115","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0049-3848(89)90210-7","article-title":"Comparison of two experimental thrombosis models in rats effects of four glycosaminoglycans","volume":"54","author":"Vogel","year":"1989","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2017.06.038_bb0120","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/1074248415578172","article-title":"Effects of rivaroxaban on platelet activation and platelet-coagulation pathway interaction: in vitro and in vivo studies","volume":"20","author":"Perzborn","year":"2015","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.thromres.2017.06.038_bb0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejphar.2011.10.009","article-title":"Biochemical and pharmacological profile of darexaban, an oral direct factor Xa inhibitor","volume":"673","author":"Iwatsuki","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.thromres.2017.06.038_bb0130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/bph.12108","article-title":"A comparison of the pharmacological profiles of prasugrel and ticagrelor assessed by platelet aggregation, thrombus formation and haemostasis in rats","volume":"169","author":"Sugidachi","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.thromres.2017.06.038_bb0135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejphar.2017.01.015","article-title":"Additive antithrombotic effect of ASP6537, a selective cyclooxygenase (COX)-1 inhibitor, in combination with clopidogrel in guinea pigs","volume":"798","author":"Sakata","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.thromres.2017.06.038_bb0140","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jacc.2003.09.041","article-title":"Optimal suppression of thromboxane A(2) formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor","volume":"43","author":"Kearney","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2017.06.038_bb0145","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.CIR.84.2.679","article-title":"Suppression of eicosanoid biosynthesis during coronary angioplasty by fish oil and aspirin","volume":"84","author":"Braden","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2017.06.038_bb0150","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.CIR.102.8.840","article-title":"Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis","volume":"102","author":"Belton","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2017.06.038_bb0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1172\/JCI27291","article-title":"Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities","volume":"116","author":"Grosser","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2017.06.038_bb0160","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1124\/jpet.300.2.393","article-title":"Cyclooxygenase isozyme expression and intimal hyperplasia in a rat model of balloon angioplasty","volume":"300","author":"Connolly","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.thromres.2017.06.038_bb0165","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1073\/pnas.061607398","article-title":"Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice","volume":"98","author":"Pratico","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.thromres.2017.06.038_bb0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1527-3466.2004.tb00132.x","article-title":"Ramatroban (BAY u 3405): a novel dual antagonist of TXA2 receptor and CRTh2, a newly identified prostaglandin D2 receptor","volume":"22","author":"Ishizuka","year":"2004","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.thromres.2017.06.038_bb0175","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0741-5214(91)90055-Y","article-title":"Prevention of stenosis after vascular reconstruction: pharmacologic control of intimal hyperplasia\u2014a review","volume":"13","author":"Clowes","year":"1991","journal-title":"J. Vasc. Surg."},{"key":"10.1016\/j.thromres.2017.06.038_bb0180","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: a perspective for the 1990s","volume":"362","author":"Ross","year":"1993","journal-title":"Nature"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817304012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384817304012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,28]],"date-time":"2019-09-28T01:11:29Z","timestamp":1569633089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384817304012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":36,"alternative-id":["S0049384817304012"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2017.06.038","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory effects of ASP6537, a selective cyclooxygenase-1 inhibitor, on thrombosis and neointima formation in rats","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2017.06.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}